awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47763039-3A13B5B8-DF57-4B6A-BBF2-A9B7938B59E5
Q47763039-3A13B5B8-DF57-4B6A-BBF2-A9B7938B59E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47763039-3A13B5B8-DF57-4B6A-BBF2-A9B7938B59E5
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study.
P2860
Q47763039-3A13B5B8-DF57-4B6A-BBF2-A9B7938B59E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47763039-3A13B5B8-DF57-4B6A-BBF2-A9B7938B59E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1158e83dac9450b684e5d051de39d5d6b18f7e67
P2860
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.